Global Innovative Platforms Inc. (GIPL)

Market Cap	24.75M +19,351.7%
Revenue (ttm)	30.00K
Net Income	-647.21K
EPS	-0.02
Shares Out	47.59M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	101
Average Volume	456
Open	0.5200
Previous Close	0.5100
Day's Range	0.5200 - 0.5200
52-Week Range	0.1100 - 2.9000
Beta	8,281.89
RSI	43.50
Earnings Date	May 15, 2026

About GIPL

Global Innovative Platforms Inc. engages in the business of testing breath to detect and assist in the treatment of disease. The company develops Heartworm breath test, which includes breath collection device, to collect shallow breath samples. It also operates VOCAM Plus and FROG platform for gas chromatography, as well as operates A.I. software to provide breath and air analysis. The company was formerly known as Canning Str Corp. and changed its name to Global Innovative Platforms Inc. in September 2021. Global Innovative Platforms Inc. was ...

• Industry: Shell Companies
• Sector: Financials
• Founded: 2020
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: GIPL